Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 4/20 | 0.37 |
| ▸ | SOS1 | Q07889 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18253757 | 0.88 | SOS1 (0.37) | HPRT1SOS1CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL18253783 | 0.85 | LMNA (0.33) | MAPTLMNAKDM4EMEN1KMT2A | |
| SCHEMBL18253762 | 0.84 | SOS1 (0.37) | HPRT1SOS1CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL19726373 | 0.82 | MYC (0.44) | CYP2C9MAPTLMNAALDH1A1KDM4E | |
| SCHEMBL18253841 | 0.81 | PTPN2 (0.38) | LMNACYP11B1CYP11B2 | |
| SCHEMBL18253789 | 0.80 | HPRT1 (0.44) | HPRT1SOS1CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL18253750 | 0.80 | HPRT1 (0.44) | HPRT1SOS1CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL17451877 | 0.80 | HPRT1 (0.44) | HPRT1SOS1CYP2C9CYP1A2CYP2C19 | |
| SCHEMBL16161039 | 0.79 | CYP1A2 (0.33) | CYP1A2LMNACYP3A4ALDH1A1HPGD | |
| SCHEMBL17451898 | 0.78 | HPRT1 (0.39) | HPRT1SOS1CYP2C9CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10297757-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-05-21 | — | — | US | disclosed |
| US-20160343950-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-24 | — | — | US | disclosed |
| US-20160343950-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160343950-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | TERT, PIEZO1, ETV6 | HPRT1 670/4885SOS1 468/4885CYP2C9 1021/4885 |
| US-10297757-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | TERT, PIEZO1, ETV6 | HPRT1 670/4885SOS1 468/4885CYP2C9 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.